This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 624087
Submitted by lobbyist on: February 21, 2017 04:15:52 PM
Accepted by Registrar on: February 21, 2017 04:19:31 PM
Designated Filer Information
Simpson, Peter |
13252 17 A Ave | |
Surrey, BC, V4A 6R9
|
604-816-7540 |
Canada |
Organization Information
GlaxoSmithKline |
GSK is one of the world's leading research-based pharmaceutical and healthcare companies. GSK is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.ca.gsk.com. |
13252 17 A Ave | |
Surrey, BC, V4A 6R9
|
604-816-7540 |
Canada |
Relevant Affiliates
Type:
Business Name | Mailing Address | Contact Information |
---|---|---|
GlaxoSmithKline |
7333 Mississauga Road
Mississauga, ON L5N 6L4 Canada |
Phone: 905-819-3000 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
February 21, 2017 | |
August 20, 2017 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Engage BC Gov't on GSK's product pipeline and their therapeutic areas. Optimize reimbursement according to the health technology assessment process in BC and Canada. Discuss health policy initiatives that will positively impact patient outcomes and contribute to healthcare sustainability.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Engage BC Gov't on GSK's product pipeline and their therapeutic areas. Optimize reimbursement according to the health technology assessment process in BC and Canada. Discuss health policy initiatives that will positively impact patient outcomes and contribute to healthcare sustainability.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
Staff of Minister | Minister of Health | February 21, 2017 | |
Staff of Minister | Minister of Health | February 21, 2017 |
Industry
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Focus on the BC life sciences ecosystem as a driver of job growth, research and investment and the contributions that are being made by GSK and by the innovative pharmaceutical industry. To advocate for a cross ministry platform to focus on the value of the innovative pharma industry
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
MLA | Virk, Amrik | Surrey-Tynehead | February 21, 2017 |
MLA | Wilkinson, Andrew | Vancouver-Quilchena | February 21, 2017 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Engage BC Gov't on GSK's product pipeline and their therapeutic areas. Optimize reimbursement according to the health technology assessment process in BC and Canada. Discuss health policy initiatives that will positively impact patient outcomes and contribute to healthcare sustainability.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
Staff of Minister | Premier | February 21, 2017 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Engage BC Gov't on GSK's product pipeline and their therapeutic areas. Optimize reimbursement according to the health technology assessment process in BC and Canada. Discuss health policy initiatives that will positively impact patient outcomes and contribute to healthcare sustainability.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
Staff of Minister | Minister of Health | February 21, 2017 | |
Staff of Minister | Minister of Health | February 21, 2017 |
Industry
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Focus on the BC life sciences ecosystem as a driver of job growth, research and investment and the contributions that are being made by GSK and by the innovative pharmaceutical industry. To advocate for a cross ministry platform to focus on the value of the innovative pharma industry
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
MLA | Virk, Amrik | Surrey-Tynehead | February 21, 2017 |
MLA | Wilkinson, Andrew | Vancouver-Quilchena | February 21, 2017 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Engage BC Gov't on GSK's product pipeline and their therapeutic areas. Optimize reimbursement according to the health technology assessment process in BC and Canada. Discuss health policy initiatives that will positively impact patient outcomes and contribute to healthcare sustainability.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
Staff of Minister | Minister of Health | February 21, 2017 | |
Staff of Minister | Minister of Health | February 21, 2017 |
Industry
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Focus on the BC life sciences ecosystem as a driver of job growth, research and investment and the contributions that are being made by GSK and by the innovative pharmaceutical industry. To advocate for a cross ministry platform to focus on the value of the innovative pharma industry
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
MLA | Virk, Amrik | Surrey-Tynehead | February 21, 2017 |
MLA | Wilkinson, Andrew | Vancouver-Quilchena | February 21, 2017 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Engage BC Gov't on GSK's product pipeline and their therapeutic areas. Optimize reimbursement according to the health technology assessment process in BC and Canada. Discuss health policy initiatives that will positively impact patient outcomes and contribute to healthcare sustainability.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
Staff of Minister | Premier | February 21, 2017 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Engage BC Gov't on GSK's product pipeline and their therapeutic areas. Optimize reimbursement according to the health technology assessment process in BC and Canada. Discuss health policy initiatives that will positively impact patient outcomes and contribute to healthcare sustainability.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
Staff of Minister | Premier | February 21, 2017 | |
Staff of Minister | Minister of Health | February 21, 2017 | |
Staff of Minister | Minister of Health | February 21, 2017 | |
Staff of Minister | Minister of Health | February 21, 2017 |
Industry
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Focus on the BC life sciences ecosystem as a driver of job growth, research and investment and the contributions that are being made by GSK and by the innovative pharmaceutical industry. To advocate for a cross ministry platform to focus on the value of the innovative pharma industry
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 21, 2017 | |
Staff of Minister | Premier | February 21, 2017 | |
Staff of Minister | Minister Responsible for Labour | February 21, 2017 | |
MLA | Bond, Shirley | Prince George-Valemount | February 21, 2017 |
MLA | Letnick, Norm | Kelowna-Lake Country | February 21, 2017 |
MLA | Thomson, Steve | Kelowna-Mission | February 21, 2017 |
MLA | Virk, Amrik | Surrey-Tynehead | February 21, 2017 |
MLA | Wilkinson, Andrew | Vancouver-Quilchena | February 21, 2017 |